Member Info for bandicoot

@BAlavi It still doesn't make sense though. The best course of action from the BOD would have been to feed steady news and build confidence with shareholders to keep the price steady, and then raise next year at a much higher share price than it is currently. This is the only thing that makes sense if you are on to something big. Anything else is just a way to keep the company afloat, at our expense.

@GLG2 honestly I'd take your losses bud. I've seen shares like this end up -99% if you hold long enough, wishing for good news.

I'd rather risk missing out than keep paying for Pouldens Christmas.

More of nothing from the BOD...

So glad I sold this at 1p pre consolidation. I've been extremely positive about WSBN up until recently, but many of the AIM veterans here were right about the BOD it seems.

Assays could still be positive, but the way the company did the double raise and the issuing of empty news doesn't add up.

I'm watching, but sat out.

Still got my eye on this, just in case. But I'll be honest, I never anticipated this dropping back down this low!

Hard to know where a good re-entry is, if there even is one.

Anyone who picked this up after reading Investors Chronicle must feel robbed.

Change: 68.77 (9,420.55%)

What we were all hoping for, just without the consolidation. Lol.

I'm still out.

@Flinn I don't disagree mate, just for me personally had to de-risk.

If things start looking up I might jump back in, but we'll see.

Wishing the best for everyone.

Sat out now, I got out just below 1p.

Still watching very closely, but assays will truly make or break this now.

Consolidation doesn't look good tbh it's used to cover up dilution ready for the next round.

Fingers crossed on assays, but seems many here were right about Poulden.

@Kemo

WSBN Website: https://wishbonegold.com/investors/rns/

Lots of additional documents.

Consolidation at these levels is usually a worry because it's used to cover up massive dilution from my experience.

Personally I hope this doesn't happen.

We need results. Nothing else.

Any doubt about a RNS the MM's will use to their advantage.

Like I said before only assays will leg this up further.

I'm starting to get impatient now tbh. Meeting is end of November, will we even get assays before then?

A rise to 1.30 is just a correction on being oversold. I wouldn't read too much into it.

A real insight will be gained in any rise beyond 1.30, which we might see tomorrow.

Either way. great entry point if you ask me.

I'm invested here, my only concern is that what they have built is not really new.

AI Agents are everywhere already and there are other competitors already doing this.

IMO what they really have going for them is that Nvidia are somewhat involved.

Amazing to see this heading the right direction again. But I do believe we'll retrace without news soon.

This is a known trader stock these days, either this is another quick in-out trade or there's an RNS lodged.

Fingers crossed.

Yep, just remember where we went from these levels about 5 RNS's ago.

If assays drop and they are good this will rocket to new highs.

1p is MM's wet dream for this, it's a fear point and weak hands will go, I expect them to test it multiple times until news drops.

Mm's have been accumulating shares for weeks.

This will open gapped up and probably go into auction very quickly

So yesterday was a tell! Huge news, this is going to fly

Finally blue again

I'm extremely tempted to take another 2M shares at this price. Just got to balance my risk / reward atm.

Chart looking like a lovely sawtooth, hoping we see a nice jump any day now.

Was in at 0.5 I'm still holding here but surprised to see this at these levels again. Wish I'd waited a bit longer.

Hoping this is just impatient holders moving on and nothing more.

Just look at the 3 month chart boys and girls.

Next leg up is imminent, 2.5 - 3p easy.

Could happen before assays. Just be patient.

Many have/will be jumping back in now.